Top 5 This Week

spot_img

Related Posts

Punjab Recalls Five Injections Over Safety Fears

Punjab Recalls Five Injections Over Safety Fears

Punjab recalls five injections after laboratory tests found them substandard or adulterated. The Directorate of Drugs Control issued a public notice on November 13, and the Provincial Quality Control Board then directed the withdrawal of the affected batches from the market.

The recall covers two batches of one medicine and one batch each of four others. Patients, pharmacies and hospitals across Punjab have been told to stop using the named batches at once.

Punjab recalls five injections: which are affected

The medicines on the recall list are Injection Dormicum, Injection Davilax, Injection Zeftrox, Injection PSOL 2mL and Injection PSOL 10mL.

Two batches of Injection Dormicum, numbered 47447 and 47661, were declared substandard after lab staff found visible particulate matter in them. Martin Dow Marker Ltd. makes the medicine.

Injection Davilax, batch DD1126, was declared adulterated. Unison Chemical Works makes it.

Injection Zeftrox, batch 677, was found substandard after sterility testing. Zafa Pharmaceutical Laboratories (Pvt.) Ltd. makes it.

Injection PSOL 2mL, batch AK164, was also found substandard after sterility testing. Injection PSOL 10mL, batch VL277, was declared substandard because of visible particulate matter. Pharmasol Private Ltd. makes both PSOL products.

Why these failures matter

The two types of failure carry different risks. Visible particles in an injection can block small blood vessels and trigger a severe reaction when the medicine enters the body. A failed sterility test means microbes may be present in the vial, which can cause infection once injected. That is why regulators treat both findings as serious, even when the medicine itself is a standard product.

What makers and sellers must do

The Directorate has told the makers and marketing authorisation holders to recall the affected batches at once. They must also hand over complete distribution records, find the root cause of each failure and submit Corrective and Preventive Action plans to the relevant regulators.

Pharmacies, medical stores, wholesalers, distributors and health facilities across Punjab have been told to stop dispensing the affected batches. They must also report their remaining stock and consumption records to the drug inspectors concerned.

Drug regulators have been told to tighten surveillance of the drug supply chain and to act under the Drugs Act, 1976, and the DRAP Act, 2012.

What patients should do

The Directorate has urged patients to stop using the affected batches. It warned that continued use may pose health risks.

Patients should check the batch number printed on the pack before they use any of the five injections. If the batch number matches one on the recall list, they should not use the medicine and should speak to their doctor or pharmacist about a safe alternative.

Health workers and patients have also been asked to report any harmful reaction linked to these medicines to the Provincial Pharmacovigilance Centre at the Directorate of Drugs Control, Punjab.

The recall is the latest in a series of drug safety actions in the province. Feature Pakistan reported earlier on a DRAP alert over fake Hexaxim vaccine, and on the Mehfooz Dawa app, which lets patients check whether a medicine is genuine. Khyber Pakhtunkhwa has also moved to test drugs closer to patients, with mobile drug testing labs now in use. The wider strain on the health system is set out in Feature Pakistan’s report on Pakistan’s doctor shortage.

Frequently asked questions

Which injections has Punjab recalled?

Punjab has recalled five injections: Dormicum (batches 47447 and 47661), Davilax (batch DD1126), Zeftrox (batch 677), PSOL 2mL (batch AK164) and PSOL 10mL (batch VL277).

Why were the injections recalled?

Lab tests found the batches substandard or adulterated. Dormicum and PSOL 10mL had visible particulate matter, Davilax was declared adulterated, and Zeftrox and PSOL 2mL failed sterility testing.

What should patients do if they have one of the recalled batches?

They should stop using it, check the batch number on the pack, and speak to their doctor or pharmacist about a safe alternative. Any harmful reaction should be reported to the Provincial Pharmacovigilance Centre at the Directorate of Drugs Control, Punjab.

What action has been taken against the makers?

The makers must recall the batches, hand over distribution records, find the root cause and submit Corrective and Preventive Action plans. Regulators can act under the Drugs Act, 1976, and the DRAP Act, 2012.

How can patients check if a medicine is genuine?

Patients can check batch details against official recall notices and use verification tools such as the DRAP Mehfooz Dawa app, which Feature Pakistan has covered in a separate report.

Feature Pakistan News Desk
Feature Pakistan News Desk
Feature Pakistan News Desk is the editorial team of Feature Pakistan, an independent digital news platform based in Pakistan. The desk reports national, world, business, sports, technology, health and education news, and every story is cross-checked against multiple sources before it is published. To reach the newsroom — including for corrections — email featurepakistanofficial@gmail.com or use the Contact page at featurepakistan.com/contact-us/.

opinion